Using berberine to reduce allergic reactions to peanuts and tree nuts
IgE Suppressing Berberine Nanomedicine for Treatment of Peanut and Tree nut Allergies
This study is looking at whether taking berberine, a natural supplement, can help reduce the allergy-triggering antibodies in people with peanut and tree nut allergies, with the hope of making life safer and easier for those affected.
Quick facts
| Grant type | R21 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | General Nutraceutical Technology, LLC NIH-funded |
| Lab location | 1 site (Briarcliff Manor, UNITED STATES) |
| Project ID | NIH-10819508 on NIH RePORTER |
What this research studies
This research investigates the use of berberine, a natural compound, to suppress the production of IgE antibodies that trigger severe allergic reactions to peanuts and tree nuts. The approach involves administering berberine orally to patients with food allergies, aiming to provide a long-lasting solution beyond current treatments. By targeting the underlying mechanisms of food allergies, this study seeks to improve the safety and quality of life for individuals affected by these conditions. The research will involve monitoring the effects of berberine on immune responses in patients with documented food allergies.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals diagnosed with peanut or tree nut allergies who are at risk of anaphylaxis.
Not a fit: Patients with allergies to foods other than peanuts or tree nuts may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to a new treatment that significantly reduces the risk of severe allergic reactions in patients with peanut and tree nut allergies.
How similar studies have performed: While the use of berberine for this specific purpose is novel, similar approaches targeting IgE suppression have shown promise in other contexts.
Where this research is happening
Briarcliff Manor, UNITED STATES
- General Nutraceutical Technology, LLC — Briarcliff Manor, United States (Active)
Researchers
- Principal investigator: Li, Xiu-Min — General Nutraceutical Technology, LLC
- Study coordinator: Li, Xiu-Min
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.